{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:32:40Z","timestamp":1783603960368,"version":"3.55.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/iop.0b013e3180500d57","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T08:36:59Z","timestamp":1179736619000},"page":"225-226","source":"Crossref","is-referenced-by-count":29,"title":["Rapamycin for Treatment of Refractory Dysthyroid Compressive Optic Neuropathy"],"prefix":"10.1097","volume":"23","author":[{"given":"Susie","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Kosmorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archopht.120.3.380","article-title":"Insights into the pathogenesis of thyroid-associated orbitopathy.","volume":"120","author":"Kazim","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence.","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","article-title":"Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis.","volume":"117","author":"Zhu","year":"1999","journal-title":"Gastroenterology"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with Graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts.","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.1997.423","article-title":"Lovastatin-induced inhibition of renal epithelial cell proliferation involves a p21 ras activated, AP-1-dependent pathway.","volume":"52","author":"Vrtovsnik","year":"1997","journal-title":"Kidney Int"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/en.2005-1375","article-title":"Immunoglobulin G from patients with Graves\u2019 disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease.","volume":"147","author":"Gianoukakis","year":"2006","journal-title":"Endocrinology"},{"key":"R9-12-20210129","first-page":"2352","article-title":"Stimulation of adipogenesis, peroxisome proliferators-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.","volume":"87","author":"Valyasevi","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e3180500d57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:37:08Z","timestamp":1620956228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-200705000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e3180500d57","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}